Department of Defense Peer Reviewed Cancer Research Program

 $150,000 – 3 years

Funding Opportunities for Fiscal Year 2016 (FY16)

The FY16 Defense Appropriations Act provides $50 million (M) to the Department of Defense Peer Reviewed Cancer Research Program (PRCRP) to support innovative, high-impact cancer research.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/ Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

FY16 PRCRP Program Announcements and General Application Instructions for the following award mechanism is posted on the website.

Congressionally Directed Topic Areas:  To be considered for funding, applications for the FY16 PRCRP must address at least one of the Topic Areas as directed by Congress.  Research applications in the areas of breast, prostate, lung (excluding mesothelioma), or ovarian cancer will not be accepted.

The FY16 PRCRP Topic Areas are listed below:

·        Bladder cancer (New for FY16) ·        Liver cancer ·        Pancreatic cancer
·        Colorectal cancer ·        Lymphoma (New for FY16) ·        Pediatric Brain Tumors (New for FY16)
·        Immunotherapy* (New for FY16) ·        Melanoma and other skin cancers ·        Stomach cancer
·        Kidney cancer ·        Mesothelioma  
·        Listeria vaccine for cancer ·        Neuroblastoma  

*As derived from the National Cancer Institute Dictionary of Cancer terms1: Immunotherapy is a type of biological therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer.  Cancers studied under this topic area should be within the scope of the Congressional language and the intent of the Program Announcement(s).

The FY16 PRCRP Military Relevance Focus Areas are listed below:

To address the cancer health needs of both deployed and non-deployed personnel, their dependents, retirees, and Veterans, the FY16 PRCRP seeks to support studies that are responsive to the Military Relevance Focus Areas listed below:

  • Militarily relevant risk factors associated with cancer (e.g., ionizing radiation, chemicals, infectious agents, and environmental carcinogens)
  • Gaps in cancer prevention, screening, early detection, diagnosis, treatment, and/or survivorship that may affect the general population but have a particularly profound impact on the health and well-being of military members, Veterans, and their beneficiaries

Applications that address exposures, conditions, or circumstances that are unique to the military, or disproportionately represented in a military beneficiary population, are the highest priority, though any applications that address the above focus areas will be considered.

Horizon Award – Preapplication due August 17, 2016

PI:  A predoctoral candidate within two years of successfully passing qualifying examinations or a postdoctoral fellow within three years of completion of his/her terminal degree (excluding medical residency or family medical leave).

Mentor:  The Mentor must be an experienced cancer researcher as demonstrated by a strong record of funding and publications.  In addition, the Mentor must demonstrate a commitment to advancing the PI’s career in cancer research.

The PI and the Mentor must be at the same organization.

  • Supports junior-level scientists to conduct impactful research with the mentorship of an experienced cancer researcher (i.e. Mentor)
  • Challenges junior scientists to develop and implement research in the cancer field
  • Emphasis on discovery
  • Must address at least one of the FY16 PRCRP Topic Areas
  • Encouraged to address at least one of the FY16 PRCRP Military Relevance Focus Areas
  • Preliminary data not required

Clinical trials are not allowed

  • Maximum funding for the entire period of performance is $150,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 3years

A pre-application is required and must be submitted through the CDMRP electronic Biomedical Research Application Portal (eBRAP) website ( prior to the pre-application deadline.  All applications must conform to the final Program Announcement(s) and General Application Instructions available for electronic downloading from the website.  Applications must be submitted through the federal government’s single-entry portal,  The application package containing the required forms for each award mechanism will also be found on  A listing of all USAMRMC funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420.

Requests for email notification of the Program Announcement(s) release may be sent to  Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor for official postings of funding opportunities.

For more information about the PRCRP or other CDMRP-administered programs, please visit the CDMRP website (